NRX Pharmaceuticals Inc [NASDAQ: NRXP] jumped around 0.96 points on Monday, while shares priced at $3.06 at the close of the session, up 45.71%.
Compared to the average trading volume of 250.99K shares, NRXP reached a trading volume of 9263468 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about NRX Pharmaceuticals Inc [NRXP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NRXP shares is $50.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NRXP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has NRXP stock performed recently?
NRX Pharmaceuticals Inc [NRXP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.80. With this latest performance, NRXP shares dropped by -42.26% in over the last four-week period, additionally sinking by -0.75% over the last 6 months – not to mention a drop of -49.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NRXP stock in for the last two-week period is set at 43.47, with the RSI for the last a single of trading hit 46.64, and the three-weeks RSI is set at 43.46 for NRX Pharmaceuticals Inc [NRXP]. The present Moving Average for the last 50 days of trading for this stock 4.47, while it was recorded at 2.40 for the last single week of trading, and 3.73 for the last 200 days.
NRX Pharmaceuticals Inc [NRXP]: Deeper insight into the fundamentals
NRX Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.36 and a Current Ratio set at 0.36.
Insider trade positions for NRX Pharmaceuticals Inc [NRXP]
The top three institutional holders of NRXP stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in NRXP stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in NRXP stock with ownership which is approximately 5.8386%.
